A market leader in large scale
Commercial Litigation Funding

The Calunius Funds provide finance for the legal and associated costs of large international arbitration and litigation disputes, enabling businesses and individuals to manage the financial risk of enforcing their meritorious commercial claims through legal action.

Arbitration and litigation funding generally covers the payment in full of lawyers, experts and court fees.  The Calunius Funds will also make provision for adverse costs to be covered in the event that proceedings are unsuccessful and the costs of the other side have to be paid.

In suitable cases, in addition to funding legal costs, the Calunius Funds can also provide corporate funding to assist businesses to manage their cash flows during sometimes lengthy proceedings.

The Calunius Funds hold more than €100million in capital commitments on behalf of our investors, with whom co-investment and syndication structures are in place that mean that no case is too large for the Calunius Funds.

The combined litigation funding experience of the London team at Calunius Capital extends over more than 40 years.  The members of the team have committed tens of millions of pounds of funding for litigation and arbitration costs since 2000, including cases of exceptional size and complexity.

The international reach of business disputes has led to Calunius funded cases being heard all over the world, including in London, Paris, Washington DC, Amsterdam, Munich, Dusseldorf and Helsinki.

All enquiries for litigation funding from the Calunius Funds should be sent to Calunius Capital, where you will find the team to be both approachable and knowledgeable.

If you would like further information please contact a member of the Calunius Capital team on +44 203 142 8330 or email us at info@calunius.com.



Calunius news and media

Calunius supports the IBA Conference 'Third-Party Funding and International Arbitration: a 360 degree perspective'

3 December 2015 in London

Calunius is pleased to be the headline sponsor of the conference ‘Third-Party Funding and International Arbitration: a 360 degree perspective’ presented by the International Bar Association (IBA) on 3 December 2015 in London, at which all relevant current aspects of the subject will be debated by senior practitioners.

Article in The Times about Litigation Funding's self-regulatory body ALF

The Times, 23 July 2015

Calunius chairman Leslie Perrin was interviewed in his capacity as chairman of ALF for an article in The Times published on 23 July 2015. The article provides an update on the activities of the litigation funding industry’s self-regulatory body.

Dutch appeals court upholds jurisdiction in cartel follow on case

21 July 2015

The Court of Appeal in Amsterdam has confirmed a first instance decision that chemicals manufacturer Kemira could be pursued before the Dutch Courts with regard to claims that relate to the sodium chlorate cartel. Finland based Kemira is the only remaining defendant after each of the other defendants settled the claims against them; one of the settling defendants (Akzo Nobel) is domiciled in the Netherlands. In line with recent developments at ECJ level the court ruled that the case may continue in the Netherlands against Kemira, notwithstanding that the only Dutch defendant has now dropped out of the case. Calunius and the CDC group, a company of which is the claimant in the matter, announced a series of strategic investments in connection with this cartel and others on 5 October 2012.


Can't find what you're looking for?

Submit a question